Cas:755-73-7 Methyl 2,2,3,3-tetrafluoro-3-methoxypropanoate manufacturer & supplier

Chemical Name:Methyl 2,2,3,3-tetrafluoro-3-methoxypropanoate

CAS.NO:755-73-7

Synonyms:Methyl 2,2,3,3-tetrafluoro-3-methoxypropanoate;Propanoic acid,2,2,3,3-tetrafluoro-3-methoxy-,methyl ester;2,2,3,3-Tetrafluoro-3-methoxypropanoic acid,methyl ester;Methyl 3-methoxytetrafluoropropanoate;Methyl 3-methoxyperfluoropropanoate;EINECS 212-048-1;methyl 2,2,3,3,-tetrafluoro-3-methoxypropionate;methyl 3-methoxy-2,2,3,3-tetrafluoropropionate;Propanoic acid, 2,2,3,3-tetrafluoro-3-methoxy-, methyl ester;methyl 3-methoxytetrafluoropropionate

Molecular Formula:C₅H₆F₄O₃

Molecular Weight:190.093

HS Code:2918990090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:157.8±35.0 °C at 760 mmHg

Density:1.3±0.1 g/cm3

Index of Refraction:1.332

PSA:35.53000

Exact Mass:190.025314

LogP:1.95

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Methyl 2,2,3,3-tetrafluoro-3-methoxypropanoate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,methyl 3-methoxytetrafluoropropionate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,methyl 3-methoxytetrafluoropropionate Use and application,EINECS 212-048-1 technical grade,usp/ep/jp grade.

Related News: The new R&D People and Culture Strategy aims to make UK the most ideal place for research and innovation, led by individuals, universities and businesses, and funders. 8-(benzyloxy)-2-((3S,4S,5R)-6-hydroxy-4-methoxy-3,5-dimethylhexyl)-5,7-dimethoxy-3-methyl-4H-chromen-4-one manufacturers The Plexxikon patents are for compounds that reduce cancer cell growth by blocking V600E mutated BRAF. Patents were filed as early as 2005. (2-Methyl-2-nitro-5-oxo-pentyl)-phosphonic acid diethyl ester suppliers The Plexxikon patents are for compounds that reduce cancer cell growth by blocking V600E mutated BRAF. Patents were filed as early as 2005. 5-[2-(6-aminopurin-9-yl)ethylamino]pentan-1-ol vendor & factory “In the past few years, the pharmaceutical industry has seen rapid growth driven by the growth of small molecules’ innovations, complex APIs and the increasing need to optimize available resources. ,In response, the strategy sets out how government will work with institutions, businesses, funders and charities to drive change in the sector, with new initiatives to encourage more young people into research, broaden career pathways in the sector and look further into the impacts of bureaucracy on researchers.